{"title":"Heart rate variability as a digital biomarker for frailty in cardiovascular patients.","authors":"Maryia Samuel, Saleena Gul Arif, Jonathan Afilalo","doi":"10.1016/j.tjfa.2024.100007","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Frailty is a syndrome associated with age-related impairments in multiple organ systems, of which the autonomic nervous system plays a fundamental role. Measurement of heart rate variability (HRV) is a non-invasive method to evaluate the autonomic activity and gain insights into cardiovascular health and potentially, frailty. A few small studies have explored the relationship between HRV and frailty, with promising but conflicting results.</p><p><strong>Objective: </strong>To investigate the relationship between HRV and frailty among adult patients with cardiovascular disease.</p><p><strong>Design: </strong>A cross-sectional study was conducted using clinical data.</p><p><strong>Setting: </strong>Data were collected from an ambulatory cardiology clinic.</p><p><strong>Participants: </strong>The cohort comprised 155 patients with a mean age of 67 years (44 % female).</p><p><strong>Measurements: </strong>HRV was assessed seated at rest for 2.5 min using a finger-based photoplethysmography (PPG) device. Frailty was assessed using the Clinical Frailty Scale (CFS), with a score ≥5 considered frail. Associations between HRV and frailty were examined using a Spearman correlation matrix and multivariable ordinal regression model. The LF/HF ratio (a frequency-domain measure reflecting imbalances between sympathetic and parasympathetic activity) was the primary HRV measure analyzed.</p><p><strong>Results: </strong>The prevalence of frailty was 15 %. Among all HRV measures, the LF/HF ratio was most closely correlated with frailty (p < 0.001). In the multivariable model, each 1 standard deviation decrease in LF/HF ratio was associated with a 1.1-point increase in CFS (95 % CI 0.7-1.6, p < 0.001). The optimal ROC cutoff at which the LF/HF ratio was associated with frailty is ≤ 0.37.</p><p><strong>Conclusions: </strong>The LF/HF ratio is inversely correlated with the CFS and independently associated with frailty. Measurement of HRV is a promising technique to enrich existing frailty scales and assist in frailty assessments in an ambulatory cardiology clinic.</p>","PeriodicalId":51629,"journal":{"name":"Journal of Frailty & Aging","volume":"14 1","pages":"100007"},"PeriodicalIF":3.3000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Frailty & Aging","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.tjfa.2024.100007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Frailty is a syndrome associated with age-related impairments in multiple organ systems, of which the autonomic nervous system plays a fundamental role. Measurement of heart rate variability (HRV) is a non-invasive method to evaluate the autonomic activity and gain insights into cardiovascular health and potentially, frailty. A few small studies have explored the relationship between HRV and frailty, with promising but conflicting results.
Objective: To investigate the relationship between HRV and frailty among adult patients with cardiovascular disease.
Design: A cross-sectional study was conducted using clinical data.
Setting: Data were collected from an ambulatory cardiology clinic.
Participants: The cohort comprised 155 patients with a mean age of 67 years (44 % female).
Measurements: HRV was assessed seated at rest for 2.5 min using a finger-based photoplethysmography (PPG) device. Frailty was assessed using the Clinical Frailty Scale (CFS), with a score ≥5 considered frail. Associations between HRV and frailty were examined using a Spearman correlation matrix and multivariable ordinal regression model. The LF/HF ratio (a frequency-domain measure reflecting imbalances between sympathetic and parasympathetic activity) was the primary HRV measure analyzed.
Results: The prevalence of frailty was 15 %. Among all HRV measures, the LF/HF ratio was most closely correlated with frailty (p < 0.001). In the multivariable model, each 1 standard deviation decrease in LF/HF ratio was associated with a 1.1-point increase in CFS (95 % CI 0.7-1.6, p < 0.001). The optimal ROC cutoff at which the LF/HF ratio was associated with frailty is ≤ 0.37.
Conclusions: The LF/HF ratio is inversely correlated with the CFS and independently associated with frailty. Measurement of HRV is a promising technique to enrich existing frailty scales and assist in frailty assessments in an ambulatory cardiology clinic.
背景:衰弱是一种与年龄相关的多器官系统损伤相关的综合征,其中自主神经系统起着重要作用。心率变异性(HRV)测量是一种评估自主神经活动和了解心血管健康和潜在虚弱的非侵入性方法。一些小型研究已经探索了HRV和虚弱之间的关系,结果令人鼓舞,但相互矛盾。目的:探讨成人心血管疾病患者HRV与虚弱的关系。设计:采用临床资料进行横断面研究。环境:数据收集于一个流动心脏病诊所。参与者:该队列包括155例患者,平均年龄67岁(44%为女性)。测量方法:使用基于手指的光电体积脉搏描记仪(PPG)装置静坐2.5分钟评估HRV。使用临床虚弱量表(CFS)评估虚弱程度,评分≥5分为虚弱。采用Spearman相关矩阵和多变量有序回归模型检验心率变异和虚弱之间的关系。LF/HF比值(反映交感神经和副交感神经活动不平衡的频域测量)是分析的主要HRV测量指标。结果:体弱多病患病率为15%。在所有HRV测量中,LF/HF比值与虚弱最密切相关(p < 0.001)。在多变量模型中,LF/HF比值每降低1个标准差,CFS增加1.1个点(95% CI 0.7-1.6, p < 0.001)。LF/HF比值与虚弱相关的最佳ROC截止值≤0.37。结论:LF/HF比值与CFS呈负相关,且与虚弱独立相关。HRV测量是一种很有前途的技术,可以丰富现有的虚弱量表,并协助门诊心脏病学的虚弱评估。
期刊介绍:
The Journal of Frailty & Aging is a peer-reviewed international journal aimed at presenting articles that are related to research in the area of aging and age-related (sub)clinical conditions. In particular, the journal publishes high-quality papers describing and discussing social, biological, and clinical features underlying the onset and development of frailty in older persons. The Journal of Frailty & Aging is composed by five different sections: - Biology of frailty and aging In this section, the journal presents reports from preclinical studies and experiences focused at identifying, describing, and understanding the subclinical pathophysiological mechanisms at the basis of frailty and aging. - Physical frailty and age-related body composition modifications Studies exploring the physical and functional components of frailty are contained in this section. Moreover, since body composition plays a major role in determining physical frailty and, at the same time, represents the most evident feature of the aging process, special attention is given to studies focused on sarcopenia and obesity at older age. - Neurosciences of frailty and aging The section presents results from studies exploring the cognitive and neurological aspects of frailty and age-related conditions. In particular, papers on neurodegenerative conditions of advanced age are welcomed. - Frailty and aging in clinical practice and public health This journal’s section is devoted at presenting studies on clinical issues of frailty and age-related conditions. This multidisciplinary section particularly welcomes reports from clinicians coming from different backgrounds and specialties dealing with the heterogeneous clinical manifestations of advanced age. Moreover, this part of the journal also contains reports on frailty- and age-related social and public health issues. - Clinical trials and therapeutics This final section contains all the manuscripts presenting data on (pharmacological and non-pharmacological) interventions aimed at preventing, delaying, or treating frailty and age-related conditions.The Journal of Frailty & Aging is a quarterly publication of original papers, review articles, case reports, controversies, letters to the Editor, and book reviews. Manuscripts will be evaluated by the editorial staff and, if suitable, by expert reviewers assigned by the editors. The journal particularly welcomes papers by researchers from different backgrounds and specialities who may want to share their views and experiences on the common themes of frailty and aging.The abstracting and indexing of the Journal of Frailty & Aging is covered by MEDLINE (approval by the National Library of Medicine in February 2016).